2016
DOI: 10.1007/s11426-016-0062-x
|View full text |Cite
|
Sign up to set email alerts
|

Biosynthesis-based artificial evolution of microbial natural products

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 100 publications
0
2
0
2
Order By: Relevance
“…For the formation of a Sch40832-like, stable series c thiopeptide, further aldehyde reduction by a NADPH-dependent reductase and thiol S -methylation by a SAM-dependent methyltransferase are necessary. Considering incomplete conversions observed in vitro with SchZ and SchY activities, the possibility that imidazopiperidine formation starts at an earlier stage cannot be excluded currently, e.g., where related enzymatic processing might occur on a side-ring opening, immature series b/a thiostrepton/thiopeptin-type intermediate. ,, The observations reported here further the understanding in the biosynthesis of thiopeptide antibiotics, which provides a unique paradigm exemplifying the process of how nature develops structural complexity and diversity from a Cys and Ser/Thr-rich peptide sequence, and thus will facilitate bioinspired engineering to expand their molecular diversity and utility. …”
Section: Discussionmentioning
confidence: 86%
“…For the formation of a Sch40832-like, stable series c thiopeptide, further aldehyde reduction by a NADPH-dependent reductase and thiol S -methylation by a SAM-dependent methyltransferase are necessary. Considering incomplete conversions observed in vitro with SchZ and SchY activities, the possibility that imidazopiperidine formation starts at an earlier stage cannot be excluded currently, e.g., where related enzymatic processing might occur on a side-ring opening, immature series b/a thiostrepton/thiopeptin-type intermediate. ,, The observations reported here further the understanding in the biosynthesis of thiopeptide antibiotics, which provides a unique paradigm exemplifying the process of how nature develops structural complexity and diversity from a Cys and Ser/Thr-rich peptide sequence, and thus will facilitate bioinspired engineering to expand their molecular diversity and utility. …”
Section: Discussionmentioning
confidence: 86%
“…在获得放线菌天然产物 BGC 的基础上, 需要考虑 如何实现后续的多种研究需求. 例如, 针对已知结构的 天然产物, 一般着眼于深入开展生物合成机制研究以及 与目标天然产物高产、优产相关的产业化研究; 针对未 知结构的天然产物, 则往往专注于沉默基因簇的激活以 及未知天然产物的挖掘 [4,5] . 无论是哪种需求, 都可能涉 及基因敲除(gene knockout)、启动子置换(promotor replacement)、定点突变(site-directed mutation)、过量表达 (over-expression)等基因编辑工作.…”
Section: 基因簇的编辑与重构unclassified
“…在以放线菌为代表的多数微生物体内, 编码天然产 物生物合成的基因往往成簇排列, 由此形成的生物合成 基因簇(biosynthetic gene cluster, BGC)除了含有编码天 然产物骨架形成和后修饰的结构基因(structural genes) 以外, 还可能含有控制合成起讫和强弱的调控基因 (regulator genes)以及解除宿主自身毒性的抗性基因 (resistance genes)、 转运基因(transporter genes)等 [3] . 这些 BGC 通过表达功能性蛋白严密控制着天然产物在体内 的生物合成过程, 是菌种遗传改造的主要靶标 [4,5] . 在遵 循生物合成一般规律的基础上, 合理运用生物学技术开 展菌种代谢网络的工程化改造, 是创制以结构和活性为 导向的新型天然产物的有效途径 [6] , 也是生产效价提 图 1 著名的活性放线菌天然产物 Figure 1 Famous bioactive natural products in actinomycetes 高、组分优化的活性天然产物的有力手段 [7] .…”
unclassified
“…[2] In addition to sequence permutation of the precursor peptide for changes in amino acid constitution, [3] individualized PTMs are necessary for specializing the common thiopeptide framework to different thiopeptide antibiotics that are composed of over 100 naturally occurring chemical entities, thereby exemplifying a process of how nature develops structural complexity and diversity from a Ser/Thr and Cys-rich sequence. [4] Scheme 1. Structures, biosynthetic pathway and enzymatic reactions associated with TsrE activity.…”
mentioning
confidence: 99%